Page 100 - 《中国药房》2021年13期
P. 100

[ 3 ]  MAHDY A M,WEBSTER N R. Perioperative systemic     travenous tranexamic acid alone for blood loss reduction
             haemostatic agents[J]. Brit J Anaesth,2004,93(6):842-  after total hip arthroplasty:a meta-analysis[J]. Int J Surg
             858.                                               (London),2017,41:34-43.
        [ 4 ]  HUANG Z,XIE X,LI L,et al. Intravenous and topical  [16]  PIGGOTT R P,LEONARD M. Is there a role for antifibri-
             tranexamic acid alone are superior to tourniquet use for  nolytics in pelvic and acetabular fracture surgery?[J]. Ir J
             primary total knee arthroplasty:a prospective,rando-  Med Sci,2016,185(1):29-34.
             mized controlled trial[J]. J Bone Joint Surg Am,2017,99  [17]  TENGBERG P T,FOSS N B,PALM H,et al. Tranexamic
             (24):2053-2061.                                     acid reduces blood loss in patients with extracapsular frac-
        [ 5 ]  HUANG Z,HUANG C,XIE J,et al. Analysis of a large  tures of the hip:results of a randomised controlled trial
             data set to identify predictors of blood transfusion in pri-  [J]. Bone Joint J,2016,98(6):747-753.
             mary total hip and knee arthroplasty[J]. Transfusion,  [18]  GEERTS W H,BERGQVIST D,PINEO G F,et al. Pre-
             2018,58(8):1855-1862.                               vention of venous thromboembolism:American college
        [ 6 ]  LIU X,ZHANG X,CHEN Y,et al. Hidden blood loss     of chest physicians evidence-based clinical practice guide-
             after total hip arthroplasty[J]. J Arthroplasty,2011,26(7):  lines(8th edition)[J]. Chest,2008,133(6 Suppl):381s-
             1100-1105.                                          453s.
        [ 7 ]  ENGEL J M,HOHAUS T,RUWOLDT R,et al. Regional  [19]  LEI J,ZHANG B,CONG Y,et al. Tranexamic acid reduces
             hemostatic status and blood requirements after total knee  hidden blood loss in the treatment of intertrochanteric frac-
             arthroplasty with and without tranexamic acid or apro-  tures with PFNA:a single-center randomized controlled
             tinin[J]. Anesthesia & Analgesia,2001,92(3):775-780.  trial[J]. J Orthop Surg Res,2017,12(1):124-130.
        [ 8 ]  SPAHN D R. Anemia and patient blood management in  [20]  DRAKOS A,RAOULIS V,KARATZIOS K,et al. Effica-
             hip and knee surgery:a systematic review of the litera-  cy of local administration of tranexamic acid for blood sal-
             ture[J]. Anesthesiology,2010,113(2):482-495.        vage in patients undergoing intertrochanteric fracture sur-
        [ 9 ]  SEICEAN A,SEICEAN S,ALAN N,et al. Preoperative    gery[J]. J Orthop Trau,2016,30(8):409-414.
             anemia and perioperative outcomes in patients who under-  [21]  WATTS C D,HOUDEK M T,SEMS S A,et al. Trane-
             go elective spine surgery[J]. Spine,2013,38(15):1331-  xamic acid safely reduced blood loss in hemi- and total
             1341.                                               hip arthroplasty for acute femoral neck fracture:a ran-
        [10]  VOCHTELOO A J,BORGER VAN DER BURG B L,             domized clinical trial[J]. J Orthop Trau,2017,31(7):345-
             MERTENS B,et al. Outcome in hip fracture patients rela-  351.
             ted to anemia at admission and allogeneic blood transfu-  [22]  WINTER S F,SANTAGUIDA C,WONG J,et al. Syste-
             sion:an analysis of 1 262 surgically treated patients[J].  mic and topical use of tranexamic acid in spinal surgery:
             BMC Musculoskeletal Disorders,2011,12:262.          a systematic review[J]. Global Spine J,2016,6(3):284-
        [11]  周宗科,黄泽宇,杨惠林,等.中国骨科手术加速康复围手                         295.
             术期氨甲环酸与抗凝血药应用的专家共识[J].中华骨与                     [23]  翟荣华,佘勇军,屈文平.脊柱外科术中和术后应用氨甲
             关节外科杂志,2019,12(2):81-88.                            环酸的临床效果[J].临床骨科杂志,2019,22(5):546-
        [12]  IMAI N,DOHMAE Y,SUDA K,et al. Tranexamic acid      549.
             for reduction of blood loss during total hip arthroplasty[J].  [24]  BIBLE J E,MIRZA M,KNAUB M A. Blood-loss ma-
             J Arthroplasty,2012,27(10):1838-1843.               nagement in spine surgery[J]. J Am Acad Orthop Surg,
        [13]  CHEN S,WU K,KONG G,et al. The efficacy of topical  2018,26(2):35-44.
             tranexamic acid in total hip arthroplasty:a meta-analy-  [25]  OU Y,WEI J,LI R,et al. Clinical research of combined
             sis[J]. BMC Musculoskeletal Disorders,2016,17:81.   intravenous administration and topical application of
        [14]  WANG C,XU G J,HAN Z,et al. Topical application of  tranexamic acid to a surgical wound during posterior lum-
             tranexamic acid in primary total hip arthroplasty:a sys-  bar fusion[J]. Surg Innov,2018,25(2):128-135.
             temic review and meta-analysis[J]. Int J Surg(London),  [26]  康鹏德,黄强,沈慧勇,等.中国骨科围手术期贫血诊疗指
             2015,15:134-139.                                    南[J].中华骨与关节外科杂志,2019,12(11):833-840.
        [15]  LIU X,LIU J,SUN G. A comparison of combined intrave-        (收稿日期:2021-02-10  修回日期:2021-04-25)
             nous and topical administration of tranexamic acid with in-                         (编辑:刘明伟)








        ·1626 ·  China Pharmacy 2021 Vol. 32 No. 13                                 中国药房    2021年第32卷第13期
   95   96   97   98   99   100   101   102   103   104   105